Assenagon Asset Management
KDNY

Assenagon Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Assenagon Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$31.7M Buy
2022
Q4 		$23.3M Sell
2022
Q3 		$28.1M Buy
2022
Q2 		$18.6M Buy
2020
Q2 		– Sell
2020
Q1 		$34K Sell
2019
Q4 		$460K Sell
2019
Q3 		$447K Sell
2019
Q2 		$834K Sell
2019
Q1 		$2.18M Buy